Overview / Abstract: |
Learn new advances in the treatment of relapsed or refractory immune thrombocytopenia, including treatment differentiation, efficacy and safety strategies, and much more. This activity features perspectives from two noted experts in the field, Dr. Keith McCrae, Director of Benign Hematology at the Cleveland Clinic Taussig Cancer Center; and Ms. Phyllis McKiernan, Advanced Practice Nurse in Blood & Marrow Stem Cell Transplantation at the John Theurer Cancer Center, Hackensack Meridian Health. STATEMENT OF NEED Immune thrombocytopenia is an acquired immune-mediated disorder defined as a peripheral blood platelet count |
Expiration |
May 24, 2022 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
0.75 CME | 0.75 MOC | 0.75 NCPD | 0.75 ILNA AMA PRA Category 1 Credit™ |
Accreditation |
ACCME, ANCC |
Presenters / Authors / Faculty |
Keith R. McCrae, MD (Chair) Phyllis McKiernan, APN, MSN, OCN® |
Sponsors / Supporters / Grant Providers |
This activity is supported by educational funding provided by Amgen. |
Keywords / Search Terms |
i3 Health i3 Health i3 Health i3 Health,Immune thrombocytopenia, online CNE, free CNE, free CE CME, free CE CME, free CE CME, NCPD, free NCPD, online NCPD, online NCPD CME Free CE CME Free CE CME Free CE CME Free CE CME |